Article Information
History
- July 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Department of Pediatrics, Virginia Commonwealth University, Richmond, VA
- 2Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA
- ↵#Correspondence: Amir A. Toor, MD, Professor of Medicine, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298. Email: amir.toor{at}vcuhealth.org
↵* Equal contribution.
Posted July 11, 2020.
Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic HCT for AML
